{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:18:10Z","timestamp":1788923890804,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,7,1]]},"DOI":"10.1038\/sj.bmt.1703081","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:36:40Z","timestamp":1032280600000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Collection of hematopoietic stem cells from patients with autoimmune diseases"],"prefix":"10.1038","volume":"28","author":[{"given":"RK","family":"Burt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NM","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CE","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Marmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,8,9]]},"reference":[{"key":"BF1703081_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0167-5699(97)01168-7","volume":"18","author":"RK Burt","year":"1997","unstructured":"Burt RK, Burns WH, Miller SD . Bone marrow transplantation for multiple sclerosis: returning to Pandora's box Immunol Today 1997 18: 559\u2013561","journal-title":"Immunol Today"},{"key":"BF1703081_CR2","first-page":"1001\u20131014; 1017","volume":"11","author":"RK Burt","year":"1997","unstructured":"Burt RK . BMT for severe autoimmune diseases: an idea whose time has come Oncology 1997 11: 1001\u20131014; 1017, discussion 1018\u20131024","journal-title":"Oncology"},{"key":"BF1703081_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2141.1997.3273144.x","volume":"99","author":"JA Snowden","year":"1997","unstructured":"Snowden JA, Brooks PM, Biggs JC . Haemopoietic stem cell transplantation for autoimmune diseases Br J Haematol 1997 99: 9\u201322","journal-title":"Br J Haematol"},{"key":"BF1703081_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00062752-199704060-00005","volume":"4","author":"A Tyndall","year":"1997","unstructured":"Tyndall A, Gratwohl A . Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease Curr Opin Hematol 1997 4: 390\u2013394","journal-title":"Curr Opin Hematol"},{"key":"BF1703081_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000040826","volume":"99","author":"S Ikehara","year":"1998","unstructured":"Ikehara S . Bone marrow transplantation for autoimmune diseases Acta Haematologica 1998 99: 116\u2013132","journal-title":"Acta Haematologica"},{"key":"BF1703081_CR6","first-page":"733","volume":"83","author":"AM Marmont","year":"1998","unstructured":"Marmont AM . Stem cell transplantation for severe autoimmune diseases: progress and problems Haematologica 1998 83: 733\u2013743","journal-title":"Haematologica"},{"key":"BF1703081_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00062752-199811000-00020","volume":"5","author":"RK Burt","year":"1998","unstructured":"Burt RK, Traynor A . Hematopoietic stem cell therapy of autoimmune diseases Curr Opin Hematol 1998 5: 472\u2013477","journal-title":"Curr Opin Hematol"},{"key":"BF1703081_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.med.51.1.115","volume":"51","author":"AM Marmont","year":"2000","unstructured":"Marmont AM . New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation Annu Rev Med 2000 51: 115\u2013134","journal-title":"Annu Rev Med"},{"key":"BF1703081_CR9","first-page":"3505\u20143514","volume":"92","author":"RK Burt","year":"1998","unstructured":"Burt RK, Traynor AE, Pope R et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation Blood 1998 92: 3505\u20143514","journal-title":"Blood"},{"key":"BF1703081_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/sj.bmt.1701129","volume":"21","author":"RK Burt","year":"1998","unstructured":"Burt RK, Traynor AE, Cohen B et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients Bone Marrow Transplant 1998 21: 537\u2013541","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first result of a pilot study Bone Marrow Transplant 1997 20: 631\u2013638","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bmt.1702180","volume":"25","author":"T Kozak","year":"2000","unstructured":"Kozak T, Havrdova E, Pit'ha J et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis Bone Marrow Transplant 2000 25: 525\u2013531","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1023\/A:1006686426090","volume":"20","author":"A Fassas","year":"2000","unstructured":"Fassas A, Anagnostopoulos A, Kazis A et al. Autologous stem cell transplantation in progressive multiple sclerosis \u2013 an interim analysis of efficacy J Clin Immunol 2000 20: 24\u201330","journal-title":"J Clin Immunol"},{"key":"BF1703081_CR14","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/1529-0131(199911)42:11<2281::AID-ANR4>3.0.CO;2-E","volume":"42","author":"RK Burt","year":"1999","unstructured":"Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients Arthr Rheum 1999 42: 2281\u20132285","journal-title":"Arthr Rheum"},{"key":"BF1703081_CR15","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/1529-0131(199911)42:11<2286::AID-ANR5>3.0.CO;2-X","volume":"42","author":"JA Snowden","year":"1999","unstructured":"Snowden JA, Biggs JC, Milliken ST et al. A phase I\/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis Arthr Rheum 1999 42: 2286\u20132292","journal-title":"Arthr Rheum"},{"key":"BF1703081_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(05)60008-6","volume":"352","author":"P Durez","year":"1998","unstructured":"Durez P, Toungouz M, Schandene L et al. Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis Lancet 1998 352: 881","journal-title":"Lancet"},{"key":"BF1703081_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/0003-4819-131-7-199910050-00005","volume":"131","author":"G McColl","year":"1999","unstructured":"McColl G, Kohsaka H, Szer J, Wicks I . High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis Ann Intern Med 1999 131: 507\u2013509","journal-title":"Ann Intern Med"},{"key":"BF1703081_CR18","doi-asserted-by":"publisher","first-page":"337\u2014338","DOI":"10.1016\/S0140-6736(05)63388-0","volume":"350","author":"DJ Joske","year":"1997","unstructured":"Joske DJ, Ma DT, Langlands DR, Owen ET . Autologous bone-marrow transplantation for rheumatoid arthritis Lancet 1997 350: 337\u2014338","journal-title":"Lancet"},{"key":"BF1703081_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(98)05399-9","volume":"353","author":"N Wulffraat","year":"1999","unstructured":"Wulffraat N, van Royen A, Bierings M et al. Autologous haematopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis Lancet 1999 353: 550\u2013553","journal-title":"Lancet"},{"key":"BF1703081_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/1529-0131(199904)42:4<807::AID-ANR26>3.0.CO;2-T","volume":"42","author":"A Martini","year":"1999","unstructured":"Martini A, Maccario R, Ravelli A et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis Arthr Rheum 1999 42: 807\u2013811","journal-title":"Arthr Rheum"},{"key":"BF1703081_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0140-6736(05)64864-7","volume":"349","author":"A Tyndall","year":"1997","unstructured":"Tyndall A, Black C, Finke J et al. Treatment of systemic sclerosis with autologous haematopoietic stem cell transplantation Lancet 1997 349: 254","journal-title":"Lancet"},{"key":"BF1703081_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/ar107","volume":"2","author":"O Rosen","year":"2000","unstructured":"Rosen O, Theil A, Massenkeil G et al. Autologous stem cell transplantation in refractory autoimmune diseases after ex vivo depletion of mononuclear cells Arthritis Res 2000 2: 327\u2013336","journal-title":"Arthritis Res"},{"key":"BF1703081_CR23","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1056\/NEJM199712113372416","volume":"337","author":"RK Burt","year":"1997","unstructured":"Burt RK, Traynor A, Ramsey-Goldman R . Hematopoietic stem-cell transplantation for systemic lupus erythematosus New Engl J Med 1997 337: 1777\u20131778","journal-title":"New Engl J Med"},{"key":"BF1703081_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1191\/096120399678847894","volume":"8","author":"L Fouillard","year":"1999","unstructured":"Fouillard L, Gorin NC, Laporte JP et al. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood Lupus 1999 8: 320\u2013323","journal-title":"Lupus"},{"key":"BF1703081_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1191\/096120398678920424","volume":"7","author":"M Musso","year":"1998","unstructured":"Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome Lupus 1998 7: 492\u2013494","journal-title":"Lupus"},{"key":"BF1703081_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/096120339700600613","volume":"6","author":"AM Marmont","year":"1997","unstructured":"Marmont AM, van Lint MT, Gualandi F, Bacigalupo A . Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration Lupus 1997 6: 545\u2013548","journal-title":"Lupus"},{"key":"BF1703081_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","volume":"356","author":"A Traynor","year":"2000","unstructured":"Traynor A, Schroeder J, Rosa R et al. Treatment of severe lupus erythematosus with high-dose intense chemotherapy and hematopoietic stem cell transplantation: a phase I study Lancet 2000 356: 701\u2013707","journal-title":"Lancet"},{"key":"BF1703081_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF . Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) Neurology 1983 33: 1444\u20131452","journal-title":"Neurology"},{"key":"BF1703081_CR29","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR et al. Skin thickness score in systemic sclerosis: an assessment interobserver variability in 3 independent studies J Rheumatol 1993 20: 1892\u20131896","journal-title":"J Rheumatol"},{"key":"BF1703081_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI: a disease activity index for lupus patients Arthr Rheum 1992 35: 630\u2013640","journal-title":"Arthr Rheum"},{"key":"BF1703081_CR31","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/sj.bmt.1701041","volume":"21","author":"SA Cleaver","year":"1998","unstructured":"Cleaver SA, Goldman JM . Use of G-CSF to mobilise PBSC in normal healthy donors \u2013 an international survey Bone Marrow Transplant 1998 21: (Suppl. 3) S29\u201331","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR32","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","volume":"54","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Stuve O, Antel JP et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor Neurology 2000 54: 2147\u20132150","journal-title":"Neurology"},{"key":"BF1703081_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.bmt.1701486","volume":"22","author":"JA Snowden","year":"1998","unstructured":"Snowden JA, Biggs JC, Milliken ST et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis Bone Marrow Transplant 1998 22: 1035\u20131041","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR34","first-page":"839","volume":"84","author":"F Locatelli","year":"1999","unstructured":"Locatelli F, Perotti C, Torretta L et al. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis Haematologica 1999 84: 839\u2013843","journal-title":"Haematologica"},{"key":"BF1703081_CR35","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/art.1780401017","volume":"40","author":"D McGonagle","year":"1997","unstructured":"McGonagle D, Rawstron A, Richards S et al. A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis Arthr Rheum 1997 40: 1838\u20131842","journal-title":"Arthr Rheum"},{"key":"BF1703081_CR36","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","volume":"95","author":"M Arpinati","year":"2000","unstructured":"Arpinati M, Green CL, Heimfeld S et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 2000 95: 2484\u20132490","journal-title":"Blood"},{"key":"BF1703081_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00007890-200002270-00041","volume":"69","author":"V Reddy","year":"2000","unstructured":"Reddy V, Hill GR, Pan L et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient Transplantation 2000 69: 691\u2013693","journal-title":"Transplantation"},{"key":"BF1703081_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bjc.6690344","volume":"80","author":"E Reyes","year":"1999","unstructured":"Reyes E, Garcia-Castro I, Esquivel F et al. Granulocytecolony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response Br J Cancer 1999 80: 229\u2013235","journal-title":"Br J Cancer"},{"key":"BF1703081_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1701413","volume":"22","author":"D Rondelli","year":"1998","unstructured":"Rondelli D, Raspadori D, Anasetti C et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells Bone Marrow Transplant 1998 22: 631\u2013637","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BFb0032323","volume":"136","author":"T Hartung","year":"1999","unstructured":"Hartung T . Immunomodulation by colony-stimulating factors Rev Physiol Biochem Pharmacol 1999 136: 1\u2013164","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"BF1703081_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/cp.1999.v66.a101210","volume":"66","author":"T Hartung","year":"1999","unstructured":"Hartung T, Doecke WD, Bundschuh D et al. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions Clin Pharmacol Ther 1999 66: 415\u2013424","journal-title":"Clin Pharmacol Ther"},{"key":"BF1703081_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1701522","volume":"23","author":"R Bellucci","year":"1999","unstructured":"Bellucci R, De Propris MS, Buccisano F et al. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF Bone Marrow Transplant 1999 23: 1\u20138","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/sj.bmt.1700924","volume":"20","author":"R Martino","year":"1997","unstructured":"Martino R, Sureda A, Brunet S . Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report Bone Marrow Transplant 1997 20: 521","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.bmt.1701828","volume":"24","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan K et al. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy Bone Marrow Transplant 1999 24: 13\u201327","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR45","first-page":"389","volume":"14","author":"HG Klingemann","year":"1994","unstructured":"Klingemann HG, Eaves CJ, Barnett MJ et al. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration Bone Marrow Transplant 1994 14: 389\u2013396","journal-title":"Bone Marrow Transplant"},{"key":"BF1703081_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/00313029109061430","volume":"23","author":"CS Feng","year":"1991","unstructured":"Feng CS, Ng MH, Szeto RS, Li EK . Bone marrow findings in lupus patients with pancytopenia Pathology 1991 23: 5\u20137","journal-title":"Pathology"},{"key":"BF1703081_CR47","first-page":"967","volume":"20","author":"T Otsuka","year":"1993","unstructured":"Otsuka T, Nagasawa K, Harada M, Niho Y . Bone marrow microenvironment of patients with systemic lupus erythematosus J Rheumatol 1993 20: 967\u2013971","journal-title":"J Rheumatol"},{"key":"BF1703081_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000163802","volume":"61","author":"AE Koch","year":"1993","unstructured":"Koch AE, Kronfeld-Harrington LB, Szekanecz Z et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease Pathobiology 1993 61: 239\u2013246","journal-title":"Pathobiology"},{"key":"BF1703081_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","volume":"117","author":"M Hasegawa","year":"1999","unstructured":"Hasegawa M, Sato S, Takehara K . Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis Clin Exp Immunol 1999 117: 159\u2013165","journal-title":"Clin Exp Immunol"},{"key":"BF1703081_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/37.11.1227","volume":"3","author":"DJ Veale","year":"1998","unstructured":"Veale DJ, Kirk G, McLaren M, Belch JJ . Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis Br J Rheumatol 1998 3: 1227\u20131228","journal-title":"Br J Rheumatol"},{"key":"BF1703081_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1749-6632.1999.tb08464.x","volume":"872","author":"T Papayannopoulou","year":"1999","unstructured":"Papayannopoulou T . Hematopoietic stem\/progenitor cell mobilization. A continuing quest for etiologic mechanisms Ann NY Acad Sci 1999 872: 187\u2013197","journal-title":"Ann NY Acad Sci"},{"key":"BF1703081_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1749-6632.1999.tb08460.x","volume":"872","author":"HE Broxmeyer","year":"1999","unstructured":"Broxmeyer HE, Kim CH, Cooper SH et al. Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors Ann NY Acad Sci 1999 872: 142\u2013162","journal-title":"Ann NY Acad Sci"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703081","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:22:17Z","timestamp":1648074137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7,1]]}},"alternative-id":["BF1703081"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703081","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,1]]},"assertion":[{"value":"18 January 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}